[go: up one dir, main page]

ZA200005189B - Stable dosage forms of fluoxetine and its enantiomers. - Google Patents

Stable dosage forms of fluoxetine and its enantiomers.

Info

Publication number
ZA200005189B
ZA200005189B ZA200005189A ZA200005189A ZA200005189B ZA 200005189 B ZA200005189 B ZA 200005189B ZA 200005189 A ZA200005189 A ZA 200005189A ZA 200005189 A ZA200005189 A ZA 200005189A ZA 200005189 B ZA200005189 B ZA 200005189B
Authority
ZA
South Africa
Prior art keywords
fluoxetine
enantiomers
dosage forms
stable dosage
stable
Prior art date
Application number
ZA200005189A
Other languages
English (en)
Inventor
Martin P Redmon
Halt Butler
Stephen A Wald
Original Assignee
Sepracor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sepracor Inc filed Critical Sepracor Inc
Publication of ZA200005189B publication Critical patent/ZA200005189B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
ZA200005189A 1998-03-27 2000-09-27 Stable dosage forms of fluoxetine and its enantiomers. ZA200005189B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/049,227 US20030013740A1 (en) 1998-03-27 1998-03-27 Stable dosage forms of fluoxetine and its enantiomers

Publications (1)

Publication Number Publication Date
ZA200005189B true ZA200005189B (en) 2001-05-22

Family

ID=21958714

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200005189A ZA200005189B (en) 1998-03-27 2000-09-27 Stable dosage forms of fluoxetine and its enantiomers.

Country Status (11)

Country Link
US (1) US20030013740A1 (xx)
EP (1) EP1067918A1 (xx)
JP (1) JP2002509882A (xx)
KR (1) KR20010034703A (xx)
CN (1) CN1303280A (xx)
AU (1) AU3205399A (xx)
BR (1) BR9909118A (xx)
CA (1) CA2325858A1 (xx)
NO (1) NO20004818L (xx)
WO (1) WO1999049857A1 (xx)
ZA (1) ZA200005189B (xx)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6372919B1 (en) * 2001-01-11 2002-04-16 Dov Pharmaceutical, Inc. (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as an anti-depressant agent
US6310250B1 (en) 2001-01-31 2001-10-30 Grayson Walker Stowell Form A of fluoxetine hydrochloride
US6313350B1 (en) 2001-01-31 2001-11-06 Grayson Walker Stowell Form a of fluoxetine hydrochloride
US6310251B1 (en) 2001-01-31 2001-10-30 Grayson Walker Stowell Form a of fluoxetine hydrochloride
US6316672B1 (en) 2001-01-31 2001-11-13 Grayson Walker Stowell Form a of fluoxetine hydrochloride
US6258853B1 (en) 2001-01-31 2001-07-10 Grayson Walker Stowell Form a of fluoxetine hydrochloride
US20070043100A1 (en) 2005-08-16 2007-02-22 Hagen Eric J Novel polymorphs of azabicyclohexane
US20080045725A1 (en) 2006-04-28 2008-02-21 Murry Jerry A Process For The Synthesis of (+) And (-)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane
EP1852108A1 (en) 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG DPP IV inhibitor formulations
PE20080251A1 (es) 2006-05-04 2008-04-25 Boehringer Ingelheim Int Usos de inhibidores de dpp iv
KR101452915B1 (ko) 2006-05-04 2014-10-21 베링거 인겔하임 인터내셔날 게엠베하 다형태
PE20140960A1 (es) 2008-04-03 2014-08-15 Boehringer Ingelheim Int Formulaciones que comprenden un inhibidor de dpp4
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
WO2010094471A1 (en) 2009-02-17 2010-08-26 Krka, D. D., Novo Mesto Pharmaceutical compositions comprising prasugrel base or its pharmaceutically acceptable acid addition salts and processes for their preparation
AR083878A1 (es) 2010-11-15 2013-03-27 Boehringer Ingelheim Int Terapia antidiabetica vasoprotectora y cardioprotectora, linagliptina, metodo de tratamiento
WO2013088255A1 (en) * 2011-12-15 2013-06-20 Alkermes Pharma Ireland Limited Prodrugs of secondary amine compounds
WO2013171166A1 (en) 2012-05-14 2013-11-21 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp-4 inhibitor for use in the treatment of sirs and/or sepsis
MX378004B (es) * 2015-12-02 2025-03-10 Jaime Samuel CHAIT AUERBACH Composición oral veterinaria con gabapentina.
MX390363B (es) 2016-06-10 2025-03-20 Boehringer Ingelheim Int Combinacion de linagliptina y metformina
CN107334744B (zh) * 2017-07-24 2020-09-04 湖南洞庭药业股份有限公司 盐酸美金刚药物组合物和制法
CN107334742B (zh) * 2017-08-18 2020-01-31 山东力诺制药有限公司 一种盐酸氟西汀分散片及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4594358A (en) * 1985-02-25 1986-06-10 Eli Lilly And Company Analgesic method
CH678920A5 (xx) * 1989-11-14 1991-11-29 Gergely Gerhard
CA2134038C (en) * 1994-06-16 1997-06-03 David Taiwai Wong Potentiation of drug response
CA2245708C (en) * 1996-02-09 2008-01-22 Bruce Joseph Roser Solid formulations containing trehalose
EP0792649A1 (en) * 1996-02-29 1997-09-03 Eli Lilly And Company Treatment of sleep disorders
CA2175939C (en) * 1996-05-07 1999-09-14 Michael Warnett Hetherington Manual capsule filling device
ATE322272T1 (de) * 1996-07-15 2006-04-15 Alza Corp Neue formulierungen zur transdermale verabreichung von fluoxetin
US5830500A (en) * 1996-07-22 1998-11-03 Pentech Pharmaceuticals, Inc. Low dose fluoxetine tablet

Also Published As

Publication number Publication date
CN1303280A (zh) 2001-07-11
JP2002509882A (ja) 2002-04-02
EP1067918A1 (en) 2001-01-17
US20030013740A1 (en) 2003-01-16
NO20004818L (no) 2000-11-23
NO20004818D0 (no) 2000-09-26
KR20010034703A (ko) 2001-04-25
CA2325858A1 (en) 1999-10-07
AU3205399A (en) 1999-10-18
BR9909118A (pt) 2001-10-16
WO1999049857A1 (en) 1999-10-07

Similar Documents

Publication Publication Date Title
ZA200005189B (en) Stable dosage forms of fluoxetine and its enantiomers.
ZA200110022B (en) Thiazoloderivatives and pharmaceutical compositions containing them.
ZA991951B (en) Compound and its use.
ZA200003392B (en) Cutting elements and methods of manufacture thereof.
ZA200203316B (en) New use and novel n-azabicyclo-amide derivatives.
GB9801363D0 (en) Novel dosage form
HUP0103884A3 (en) Arylsulfonanilide urea-derivatives, pharmaceutical compositions containing them and their use
EP1112252A4 (en) KAPPA AGONIST COMPOUNDS AND PHARMACEUTICAL FORMULATIONS THEREOF
PL351250A1 (en) Antipicornaviral compounds, their preparation and use
ZA991590B (en) Indole derivatives and pharmaceutical compositions comprising the same.
ZA200006300B (en) Composition comprising tumor cells and extracts and method of using thereof.
PL353214A1 (en) Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-ones and their use as lipase inhibitors
ZA200006020B (en) Voacamine as anti-malarial agent and anti-malarial agent containing voacamine.
ZA991232B (en) New compound and pharmaceutical compositions thereof.
ZA985709B (en) Encapsulated solution dosage forms of sertraline.
HUP0104723A3 (en) New 2-aminothiazol-fused 2-aminoindans and 2-aminotetralins and their use
HUP0101341A3 (en) New drug combinations
ZA200109120B (en) Use of Arylalkanoylpyridazines.
GB9807586D0 (en) Enzymes and their use
HUP0103006A3 (en) Substituted betha-diketones, pharmaceutical compositions containing them and their use
ZA99835B (en) Preparation of microballoons.
GB9805464D0 (en) Construction of ioniser
IL126732A0 (en) Pro drug
ZA200110325B (en) Highly selective norepinephrine reuptake inhibitors and methods of using the same.
ZA995435B (en) Prestressing of supports.